Under conditions of inherent or induced
mitochondrial dysfunction,
cancer cells manifest overlapping metabolic phenotypes, suggesting that they may be targeted via a common approach. Here, we use multiple oxidative phosphorylation (OXPHOS)-competent and incompetent
cancer cell pairs to demonstrate that treatment with α-ketoglutarate (aKG)
esters elicits rapid death of OXPHOS-deficient
cancer cells by elevating intracellular aKG concentrations, thereby sequestering
nitrogen from
aspartate through
glutamic-oxaloacetic transaminase 1 (GOT1). Exhaustion of
aspartate in these cells resulted in immediate depletion of adenylates, which plays a central role in mediating mTOR inactivation and inhibition of glycolysis. aKG
esters also conferred cytotoxicity in a variety of
cancer types if their cell respiration was obstructed by
hypoxia or by chemical inhibition of the electron transport chain (ETC), both of which are known to increase
aspartate and GOT1 dependencies. Furthermore, preclinical mouse studies suggested that cell-permeable aKG displays a good biosafety profile, eliminates
aspartate only in OXPHOS-incompetent
tumors, and prevents their growth and
metastasis. This study reveals a novel cytotoxic mechanism for the metabolite aKG and identifies cell-permeable aKG, either by itself or in combination with ETC inhibitors, as a potential anticancer approach. SIGNIFICANCE: These findings demonstrate that OXPHOS deficiency caused by either
hypoxia or mutations, which can significantly increase
cancer virulence, renders
tumors sensitive to aKG
esters by targeting their dependence upon GOT1 for
aspartate synthesis. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/17/3492/F1.large.jpg.